CenterBook Partners’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,385
Closed -$383K 698
2025
Q4
$383K Buy
+4,385
New +$333K 0.02% 509
2025
Q2
Sell
-36,871
Closed -$2.7M 543
2025
Q1
$2.7M Buy
+36,871
New +$3.05M 0.17% 157
2024
Q1
Sell
-7,198
Closed -$384K 427
2023
Q4
$384K Sell
7,198
-25,018
-78% -$1.22M 0.05% 342
2023
Q3
$1.6M Sell
32,216
-1,255
-4% -$70.2K 0.2% 175
2023
Q2
$1.99M Buy
+33,471
New +$1.91M 0.25% 142

Other funds holding GMED

CenterBook Partners's GMED Position: Q1 2026 in Review

CenterBook Partners sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 4,385 shares — an estimated $383K sold.

CenterBook Partners first reported a position in GMED in Q2 2023 and held it in 5 quarters. The position peaked at $2.7M in Q1 2025. 609 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • CenterBook Partners reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • CenterBook Partners sold 4,385 Globus Medical shares in Q1 2026, an estimated $383K.
  • CenterBook Partners first reported a position in Globus Medical in Q2 2023 and held it in 5 quarters.
  • CenterBook Partners's Globus Medical position peaked at $2.7M in Q1 2025.
  • 609 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.